Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) ELISA Kits

The protein encoded by TNFRSF19 is a member of the TNF-receptor superfamily. Zusätzlich bieten wir Ihnen Tumor Necrosis Factor Receptor Superfamily, Member 19 Antikörper (100) und Tumor Necrosis Factor Receptor Superfamily, Member 19 Proteine (20) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
TNFRSF19 55504 Q9NS68
TNFRSF19 29820 Q9JLL3
TNFRSF19 290300  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Tumor Necrosis Factor Receptor Superfamily, Member 19 ELISA Kits auf antikoerper-online.de

Showing 3 out of 16 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 100 pg/mL 0.55-400 ng/mL 96 Tests Anmelden zum Anzeigen 3 bis 4 Tage
$548.15
Details
Maus 0.2 ng/mL 0.25-60 ng/mL 96 Tests Anmelden zum Anzeigen 3 bis 4 Tage
$548.15
Details
Ratte 30 pg/mL 62.5-4000 pg/mL Representative Standard Curve 96 Tests Anmelden zum Anzeigen 15 bis 16 Tage
$525.00
Details

Weitere ELISA Kits für Tumor Necrosis Factor Receptor Superfamily, Member 19 Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) Interaktionspartner

  1. isruption of the TROY/RKIP interaction using the TAT-TROY (234-371 aa) protein reduced the glioma development in xenografted mice. This suggests the TROY/RKIP interaction is a potential target for therapy of gliomas.

  2. TROY signaling role in the glioblastoma cell invasion and survival.PDZ-RhoGEF is an effector of TROY signaling.

  3. Glioblastoma tumors (GB) with elevated TROY expression have a statistically positive correlation with increased EGFR expression. TROY expression significantly increases the capacity of EGF to stimulate GB cell invasion, whereas depletion of TROY expression blocks EGF stimulation of glioblastoma cell invasion. TROY expression modulates EGFR signaling by facilitating EGFR activation and delaying its internalization.

  4. TNFRSF19 may contribute to the development of colorectal tumors with deregulated beta-catenin activity.

  5. Results show aberrant expression and/or signaling by TROY as a contributor to the dispersion of glioblastoma cells and therapeutic resistance.

  6. the association of RhoGDIalpha with TROY contributed to TROY-dependent RhoA activation and neurite outgrowth inhibition after Nogo-66 stimulation.

  7. TROY is up-regulated in human colorectal cancer cell lines and in intestinal tumors in mice. It functions as a negative modulator of the Wnt pathway in LGR5-positive stem cells.

  8. study demonstrated that TNFR2 and TROY mRNA levels are enhanced in cutaneous squamous cell carcinoma cells compared to healthy ones in a Tunisian population

  9. The FAM134B and TNFRSF19 showed a dramatically strong synergistic epistasis in explaining the genetic dissection of the susceptibility to complex vascular dementia.

  10. TNFRSF19 overexpression in glioma cells activates Rac1 signaling in a Pyk2-dependent manner to drive glioma cell invasion and migration

  11. Findings provide new insights into the pathogenesis of NPC by highlighting the involvement of pathways related to TNFRSF19 and MDS1-EVI1 in addition to HLA molecules.

  12. TROY regulates melanoma growth.

  13. the ternary complex of NgR/TROY/LINGO-1 expressed on astrocytes, macrophages/microglia and neurones, by interacting with Nogo-A on oligodendrocytes, might modulate glial-neuronal interactions in demyelinating lesions of multiple sclerosis

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) Interaktionspartner

  1. data show that Troy marks a renal stem/progenitor cell population in the developing kidney that in adult kidney contributes to homeostasis, predominantly of the collecting duct, and regeneration.

  2. High TROY expression is associated with glioblastoma cell invasion.

  3. TROY negatively modulates remyelination in the central nervous system.

  4. the association of RhoGDIalpha with TROY contributed to TROY-dependent RhoA activation and neurite outgrowth inhibition after Nogo-66 stimulation.

  5. TROY is up-regulated in human colorectal cancer cell lines and in intestinal tumors in mice. It functions as a negative modulator of the Wnt pathway in LGR5-positive stem cells.

  6. TROY is expressed in microglia, involved in their migration and targeted by propentofylline.

  7. TROY plays some important roles in neurogenesis of embryonic stages.

  8. This gene was a target of WNT signaling in the dorsal somite.

  9. Analysis of expression patterns of eda, edar and tnfrsf19 in mouse embryogenesis.

  10. Both mRNA and protein of TROY are detected in the olfactory bulb during embryogenesis; TROY expression is most intense in the inner layer. In the postnatal olfactory bulb, TROY-expressing cells are also detected in the glomerular layer.

  11. Our results implicate TROY in mediating myelin inhibition, offering new insights into the molecular mechanisms of regeneration failure in the adult nervous system.

  12. Troy, broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors.

  13. Data suggest that signaling from TROY regulates neuronal differentiation at least in part.

  14. TROY was expressed in uncommitted precursor cells and astroglial lineage cells, suggesting that TROY plays some roles in the regulation of gliogenesis in the adult CNS.

  15. Troy protein is expressed in the matrix region of developing hair follicles and may have a subtle function in skin appendage development.

  16. TROY was expressed in some specific subsets of glial cells in the olfactory bulb, including OECs, and may play some roles in the developing and adult olfactory system

  17. functional overlap of Troy and Eda signalling pathways is mediated by NF-kappaB independent pathways

Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is highly expressed during embryonic development. It has been shown to interact with TRAF family members, and to activate JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. Alternatively spliced transcript variants encoding distinct isoforms have been described.

Genbezeichner und Symbole assoziert mit TNFRSF19

  • TNF receptor superfamily member 19 (TNFRSF19) Antikörper
  • tumor necrosis factor receptor superfamily, member 19 (TNFRSF19) Antikörper
  • tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19) Antikörper
  • TNF receptor superfamily member 19 (Tnfrsf19) Antikörper
  • AL023044 Antikörper
  • AW123854 Antikörper
  • DKFZp468A0320 Antikörper
  • RGD1564996 Antikörper
  • TAJ Antikörper
  • TAJ-ALPHA Antikörper
  • TNFRSF19 Antikörper
  • TRADE Antikörper
  • Troy Antikörper

Bezeichner auf Proteinebene für TNFRSF19

tumor necrosis factor receptor superfamily member 19 , tumor necrosis factor receptor superfamily, member 19 , tumor necrosis factor receptor superfamily member 19-like , toxicity and JNK inducer , Toxicity and JNK inducer

GENE ID SPEZIES
418943 Gallus gallus
452480 Pan troglodytes
486042 Canis lupus familiaris
768037 Bos taurus
100172324 Pongo abelii
100340235 Oryctolagus cuniculus
100393522 Callithrix jacchus
100466414 Ailuropoda melanoleuca
100605138 Nomascus leucogenys
55504 Homo sapiens
29820 Mus musculus
290300 Rattus norvegicus
Ausgewählte Anbieter für Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) ELISA Kits
Haben Sie etwas anderes gesucht?